BioCorRx Inc. (BICX)

0.7500 0.0000 (0.00%) At close: 01:22PM EDT

BioCorRx Inc.

2390 East Orangewood Avenue
Suite 500
Anaheim, CA 92806
United States
714 462 4880
https://www.biocorrx.com

Sector(s): Healthcare
Industry: Medical Care Facilities
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Lourdes Felix	CEO, CFO & Director	250k	N/A	1968
Mr. Louis Charles Lucido	President & Director	60k	N/A	1948
Dr. George N. Fallieras	Medical Consultant	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

Corporate governance

BioCorRx Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.